In contrast, the study from Oki et al. included traditional translocation defined MYC/BCL2 DHL, MYC/BCL6 DHL, and MYC/BCL2/BCL6 triple hit lymphoma, as well as cases with extracopies of MYC, BCL2, or BCL6. In keeping with other studies, the results we present also show that achieving CR is an independent prognostic factor for OS regardless of type of frontline chemotherapy. Here, BCL6 is linked to lymphoma.